Bioactive glasses: From parent 45S5 Composition to Scaffold-Assisted Tissue-Healing Therapies

285Citations
Citations of this article
537Readers
Mendeley users who have this article in their library.

Abstract

Nowadays, bioactive glasses (BGs) are mainly used to improve and support the healing process of osseous defects deriving from traumatic events, tumor removal, congenital pathologies, implant revisions, or infections. In the past, several approaches have been proposed in the replacement of extensive bone defects, each one with its own advantages and drawbacks. As a result, the need for synthetic bone grafts is still a remarkable clinical challenge since more than 1 million bone-graft surgical operations are annually performed worldwide. Moreover, recent studies show the effectiveness of BGs in the regeneration of soft tissues, too. Often, surgical criteria do not match the engineering ones and, thus, a compromise is required for getting closer to an ideal outcome in terms of good regeneration, mechanical support, and biocompatibility in contact with living tissues. The aim of the present review is providing a general overview of BGs, with particular reference to their use in clinics over the last decades and the latest synthesis/processing methods. Recent advances in the use of BGs in tissue engineering are outlined, where the use of porous scaffolds is gaining growing importance thanks to the new possibilities given by technological progress extended to both manufacturing processes and functionalization techniques.

Cite

CITATION STYLE

APA

Fiume, E., Barberi, J., Verné, E., & Baino, F. (2018, March 16). Bioactive glasses: From parent 45S5 Composition to Scaffold-Assisted Tissue-Healing Therapies. Journal of Functional Biomaterials. MDPI AG. https://doi.org/10.3390/jfb9010024

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free